Novel pyrrolo[3,2-f]quinolines:: Synthesis and antiproliferative activity

被引:37
作者
Ferlin, MG [1 ]
Gatto, B [1 ]
Chiarelotto, G [1 ]
Palumbo, M [1 ]
机构
[1] Univ Padua, Dept Pharmaceut Sci, I-35131 Padua, Italy
关键词
D O I
10.1016/S0968-0896(01)00071-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Novel pyrrolo[3,2,f]quinoline derivatives have been synthesized and tested as antiproliferative agents. They are characterized by an angular aromatic tricyclic system, to which a methyl group can be bound at position 7, and by a methanesulfonanisidide side chain as such, or lacking the m-methoxy substituent at position 1. The novel compounds were shown to exhibit cell growth inhibitory properties when tested against the NCI panel of cell lines, in particular those obtained from leukemias. Although the compounds are able to stimulate topoisomerase II poisoning at high concentration. the cell growth inhibition properties do not appear to rest principally on this mechanism of action. Overall, the most active proved to be compound 9, having the m-methoxy substituent typical of amsacrine, followed by the 7-methyl derivative 10 and by the unsubstituted compound 8. Comparison with previously investigated regioisomers shows modulation of activity dictated by the position and conformational freedom of sidechain groups. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1843 / 1848
页数:6
相关论文
共 13 条
[1]   NEW METHOD FOR METHYLATION OF AMINES [J].
BORCH, RF ;
HASSID, AI .
JOURNAL OF ORGANIC CHEMISTRY, 1972, 37 (10) :1673-&
[2]  
Boyd M. R., 1989, CANCER PRINCIPLES PR, V3, P1
[3]   ANTICANCER ANILINOACRIDINES - A PROCESS SYNTHESIS OF THE DISUBSTITUTED AMSACRINE ANALOG CI-921 [J].
BRENNAN, ST ;
COLBRY, NL ;
LEEDS, RL ;
LEJA, B ;
PRIEBE, SR ;
REILY, MD ;
SHOWALTER, HDH ;
UHLENDORF, SE ;
ATWELL, GJ ;
DENNY, WA .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1989, 26 (05) :1469-1476
[4]  
Canal P, 1998, Pathol Oncol Res, V4, P171
[5]  
Christian MC, 1997, SEMIN ONCOL, V24, P219
[6]  
Conrad M., 1887, Ber. Dtsch. Chem. Ges, V20, P944, DOI DOI 10.1002/CBER.188702001215
[7]  
Conrad M., 1891, BER, V24, P2990
[8]  
Cornarotti M, 1996, MOL PHARMACOL, V50, P1463
[9]  
FELRIN MG, 2000, BIOORGAN MED CHEM, V8, P1415
[10]  
Gould R.G., 1939, J. Am. Chem. Soc, V61, P2890, DOI DOI 10.1021/JA01265A088